Biological
Influenza A virus subtype H3N2 clinical trials
- studies test it
- 6
- open now
- 1
- in phase 3
- 0
- first study started
- 2012
Keep track of what changes. Save the influenza A virus subtype H3N2 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStudies by the year they started
6 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Duke University (1) · Imperial College London (1) · SGS Life Sciences, a division of SGS Belgium NV (1) · University of Sao Paulo General Hospital (1) · Dalhousie University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses influenza A virus subtype H3N2 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic PreparednessRecruitingPhase 1Dalhousie UniversityNCT07305207Written as Intranasal inoculation of RG-A/Texas/71/2017 (H3N2) influenza in each naris on Day 1 of the study.
- Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza StrainCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT04978454Written as Influenza RG-A/Texas/71/2017 (H3N2) Challenge
- Single Dose Texas 2017 (H3N2) Challenge StudyCompletedPhase 1Duke UniversityNCT06476275Written as Influenza A/Texas/71/2017 (H3N2)
- Cell Mediated Immunity Against RSV and Influenza in a Human Experimental ChallengeCompletedNot applicableImperial College LondonNCT02755948Written as Influenza A/Belgium/4217/2015 (H3N2)
- A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy VolunteersCompletedPhase 1SGS Life Sciences, a division of SGS Belgium NVNCT04372719Written as H3N2
- Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic DiseasesCompletedPhase 4University of Sao Paulo General HospitalNCT03540823Written as Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)
Given in every arm · 1 — influenza A virus subtype H3N2 is usual care beside what is tested
Codes
What other systems call influenza A virus subtype H3N2 · ClinicalTrials.gg INT014440
- Wikidata Q13399926influenza A virus subtype H3N2One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q13399926 | influenza A virus subtype H3N2 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.